Precision Immunotherapy™
Investor Relations

Email Alerts

Email Address *
Mailing Lists *

Enter the code shown above.

Analyst Coverage

Institution Analyst Contact
Aegis Capital CorpRobert
Chardan Capital Markets Keay Nakae
Edison Pooya Hemami
IFS Securities David Bouchey
Maxim Group Jason Kolbert

Opexa Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Opexa Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Opexa Therapeutics, Inc. or its management. Opexa Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.